LOINCActiveBoth

LOINC Code 72520-0: FLT3 gene.p.Asp835+Ile836 mutations Molgen Ql (Bld/Tiss)

72520-0 is a LOINC code used to identify FLT3 gene.p.Asp835+Ile836 mutations Molgen Ql (Bld/Tiss) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component FLT3 gene.p.Asp835+Ile836 mutations. It is commonly used with the system or sample type Bld/Tiss.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component FLT3 gene.p.Asp835+Ile836 mutations. It is commonly used with the system or sample type Bld/Tiss.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Molgen

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • FLT3 gene.p.Asp835+Ile836 mutations [Presence] in Blood or Tissue by Molecular genetics method
  • FLT3 gene.p.Asp835+Ile836 mutations
  • Point mutations and deletions of codons D835 and I836 within the second tyrosine kinase domain (protein activation loop) of the FLT3 gene are detected by molecular genetic methods (e.g. PCR-based assays). This code was created for, but not limited to Invivoscribe's LeukoStrat(tm) FLT3 Gel Detection Mutation Assay, which detects the presence or absence of either D835 or I836 mutations within the second TKD but does not identify specific TKD mutations. FLT3-TKD mutations occur in approximately 7% of patients with acute myelogenous leukemia (AML).
  • Acute myeloid leukemia; AML; Blood; CD135; FL cytokine receptor precursor; FLK2; FLK-2; FLT3 p.D835; FLT3 p.D835+I836; FLT3 TKD; FLT3 tyrosine kinase domain; fms-like tyrosine kinase 3; fms-related tyrosine kinase 3; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutation; Muts; Ordinal; P prime; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stem cell tyrosine kinase 1; STK1; STK-1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

FLT3 gene.p.Asp835+Ile836 mutations Molgen Ql (Bld/Tiss)FLT3 gene.p.Asp835+Ile836 mutations [Presence] in Blood or Tissue by Molecular genetics methodFLT3 p.D835+I836 Bld/T QlFLT3 gene.p.Asp835+Ile836 mutationsMOLPATH.MUTFLT3 gene.p.Asp835+Ile836 mutations, Blood or tissue specimenPrThr

Frequently asked questions

Code details

Code72520-0
SystemLOINC
Display nameFLT3 gene.p.Asp835+Ile836 mutations Molgen Ql (Bld/Tiss)
DescriptionFLT3 gene.p.Asp835+Ile836 mutations
Short nameFLT3 p.D835+I836 Bld/T Ql
ComponentFLT3 gene.p.Asp835+Ile836 mutations
PropertyPrThr
TimingPt
System (specimen)Bld/Tiss
ScaleOrd
MethodMolgen
ClassMOLPATH.MUT
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.42
Last changed2.73

Consumer names

FLT3 gene.p.Asp835+Ile836 mutations, Blood or tissue specimen

Part names

FLT3 gene.p.Asp835+Ile836 mutationsPrThrPtBld/TissOrdMolgenPresence or ThresholdPoint in time (spot)Blood or TissueMolecular genetics

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.